Literature DB >> 26622614

Expression and clinical significance of focal adhesion kinase and adrenomedullin in epithelial ovarian cancer.

Mingqun Li1, L I Hong2, Meimei Liao3, Guanglin Guo2.   

Abstract

The aim of the present study was to investigate the expression of focal adhesion kinase (FAK) and adrenomedullin (ADM) and determine their clinical significance and cooperative role in human epithelial ovarian cancer. The expression of FAK and ADM was investigated in epithelial ovarian cancer, benign ovarian tumors and normal control tissues by immunohistochemical staining and optical microscopy. The FAK and ADM expression and correlation with clinicopathological parameters was analyzed using SPSS 13.0 software. The expression of FAK and ADM in epithelial ovarian cancer was significantly higher compared with that in benign tumors or normal ovarian tissues (P<0.01); however, no significant difference was observed between benign tumors and normal tissues (P>0.05). The expression of FAK was found to be correlated with histological grade, clinical stage, lymph node metastasis and prognosis (P<0.05), but exhibited no significant association with patient age or histological type (P>0.05). The expression of ADM was significantly correlated with pathological grade, lymph node metastasis and prognosis (P<0.05), but not with age, clinical stage or histological type (P>0.05). The Spearman's rank correlation analysis revealed a positive correlation between FAK and ADM expression (r=0.314). FAK and ADM were more highly expressed in epithelial ovarian cancer compared with benign tumors or normal ovarian tissues. Furthermore, FAK and ADM may play a cooperative role; specifically, FAK may upregulate ADM in the invasion and migration of epithelial ovarian cancer. Thus, FAK and ADM may represent potential biomarkers for evaluating the malignant potential and prognosis of ovarian cancer.

Entities:  

Keywords:  adrenomedullin; focal adhesion kinase; ovarian cancer

Year:  2015        PMID: 26622614      PMCID: PMC4508992          DOI: 10.3892/ol.2015.3278

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  20 in total

1.  Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  N Colombo; M Peiretti; G Parma; M Lapresa; R Mancari; S Carinelli; C Sessa; M Castiglione
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability.

Authors:  Ying-Tang Huang; Lung-Ta Lee; Ping-Ping H Lee; Yung-Sheng Lin; Ming-Ting Lee
Journal:  Anticancer Res       Date:  2005 May-Jun       Impact factor: 2.480

3.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 4.  Adrenomedullin functions as an important tumor survival factor in human carcinogenesis.

Authors:  Frank Cuttitta; Rubén Pío; Mercedes Garayoa; Enrique Zudaire; Miguel Julián; Ted H Elsasser; Luis M Montuenga; Alfredo Martínez
Journal:  Microsc Res Tech       Date:  2002-04-15       Impact factor: 2.769

5.  p125Fak focal adhesion kinase is a substrate for the insulin and insulin-like growth factor-I tyrosine kinase receptors.

Authors:  V Baron; V Calléja; P Ferrari; F Alengrin; E Van Obberghen
Journal:  J Biol Chem       Date:  1998-03-20       Impact factor: 5.157

6.  Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.

Authors:  Anil K Sood; Jeremy E Coffin; Galen B Schneider; Mavis S Fletcher; Barry R DeYoung; Lynn M Gruman; David M Gershenson; Michael D Schaller; Mary J C Hendrix
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 7.  Pathway modulations and epigenetic alterations in ovarian tumorbiogenesis.

Authors:  Sabita N Saldanha; Trygve O Tollefsbol
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

8.  The Interaction of Adrenomedullin and Macrophages Induces Ovarian Cancer Cell Migration via Activation of RhoA Signaling Pathway.

Authors:  Xiaoyan Pang; Hai Shang; Boya Deng; Fang Wen; Yi Zhang
Journal:  Int J Mol Sci       Date:  2013-01-29       Impact factor: 5.923

9.  The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis.

Authors:  Leonid L Nikitenko; Russell Leek; Stephen Henderson; Nischalan Pillay; Helen Turley; Daniele Generali; Sarah Gunningham; Helen R Morrin; Andrea Pellagatti; Margaret C P Rees; Adrian L Harris; Stephen B Fox
Journal:  Clin Cancer Res       Date:  2013-08-22       Impact factor: 12.531

10.  Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models.

Authors:  Natalie O Karpinich; Samantha L Hoopes; Daniel O Kechele; Patricia M Lenhart; Kathleen M Caron
Journal:  Curr Hypertens Rev       Date:  2011-12
View more
  11 in total

1.  Deciphering Biophysical Modulation in Ovarian Cancer Cells.

Authors:  Makhdoom Sarwar; Peter H Sykes; Kenny Chitcholtan; John J Evans
Journal:  Cell Biochem Biophys       Date:  2021-01-12       Impact factor: 2.194

2.  Adrenomedullin inhibits tumor metastasis and is associated with good prognosis in triple-negative breast cancer patients.

Authors:  Li-Li Liu; Shi-Lu Chen; Yu-Hua Huang; Xia Yang; Chun-Hua Wang; Jie-Hua He; Jing-Ping Yun; Rong-Zhen Luo
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

3.  Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis.

Authors:  Shengjin Cui; Shuang Lou; Jingying Feng; Xi Tang; Xiaowei Xiao; Rong Huang; Weiquan Guo; Yiwen Zhou; Feixia Huang
Journal:  Transl Cancer Res       Date:  2022-04       Impact factor: 1.241

4.  Prognostic Value of Focal Adhesion Kinase (FAK) in Human Solid Carcinomas: A Meta-Analysis.

Authors:  Xiao-Qing Zeng; Na Li; Li-Li Ma; Yu-Jen Tseng; Nai-Qing Zhao; Shi-Yao Chen
Journal:  PLoS One       Date:  2016-09-16       Impact factor: 3.240

5.  Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.

Authors:  Yi Zhang; Yang Xu; Jian Ma; Xiaoyan Pang; Mei Dong
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

6.  Increasing sensitivity to DNA damage is a potential driver for human ovarian cancer.

Authors:  Yimei Jin; Xin Xu; Xuemeng Wang; Henry Kuang; Michael Osterman; Shi Feng; Deqiang Han; Yu Wu; Mo Li; Hongyan Guo
Journal:  Oncotarget       Date:  2016-08-02

7.  JMJD1A, H3K9me1, H3K9me2 and ADM expression as prognostic markers in oral and oropharyngeal squamous cell carcinoma.

Authors:  Lucas de Lima Maia; Gabriela Tonini Peterle; Marcelo Dos Santos; Leonardo Oliveira Trivilin; Suzanny Oliveira Mendes; Mayara Mota de Oliveira; Joaquim Gasparini Dos Santos; Elaine Stur; Lidiane Pignaton Agostini; Cinthia Vidal Monteiro da Silva Couto; Juliana Dalbó; Aricia Leone Evangelista Monteiro de Assis; Anderson Barros Archanjo; Ana Maria Da Cunha Mercante; Rossana Veronica Mendoza Lopez; Fábio Daumas Nunes; Marcos Brasilino de Carvalho; Eloiza Helena Tajara; Iúri Drumond Louro; Adriana Madeira Álvares-da-Silva
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

8.  Increased expression of FAK isoforms as potential cancer biomarkers in ovarian cancer.

Authors:  Manuel Nolasco-Quiroga; Marisol Rosas-Díaz; José Moreno; Ricardo Godínez-Aguilar; María José López-Ibarra; Patricia Piña-Sánchez; Isabel Alvarado-Cabrero; Gerardo Vázquez-Gómez; Leticia Rocha-Zavaleta; Diego Arenas-Aranda; Fabio Salamanca-Gómez
Journal:  Oncol Lett       Date:  2019-03-15       Impact factor: 2.967

Review 9.  Role of Focal Adhesion Kinase in Small-Cell Lung Cancer and Its Potential as a Therapeutic Target.

Authors:  Frank Aboubakar Nana; Marie Vanderputten; Sebahat Ocak
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

10.  Increased Expression and Activation of FAK in Small-Cell Lung Cancer Compared to Non-Small-Cell Lung Cancer.

Authors:  Frank Aboubakar Nana; Delphine Hoton; Jérôme Ambroise; Marylène Lecocq; Marie Vanderputten; Yves Sibille; Bart Vanaudenaerde; Charles Pilette; Caroline Bouzin; Sebahat Ocak
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.